Altunoz Yusuf, Karakus Yilmaz Banu, Topcu Hatice, Cetinkal Gökhan, İkizceli İbrahim, Yigit Yavuz
Emergency Medicine Specialist, Şanlıurfa Viranşehir Devlet Hastanesi, Şanlıurfa, TUR.
Emergency Department, Alanya Alaaddin Keykubat University, Medical School, Antalya, TUR.
Cureus. 2023 Jan 1;15(1):e33202. doi: 10.7759/cureus.33202. eCollection 2023 Jan.
The HEARTS3 score is used to predict acute coronary syndrome by evaluating the findings of chest pain patients at the end of the second hour. Additionally, the American College of Cardiology (ACC)/American Heart Association (AHA) 2014 non-ST elevation acute coronary syndrome (NSTE-ACS) management guideline suggests assessing cardiac troponin levels at the third and sixth hours as a class 1A recommendation. This study aimed to explore the value of the HEARTS3 score for the evaluation of patients with chest pain and its utility for determining whether a patient is eligible for early discharge from the emergency department.
This study was prospectively conducted between March 1, 2016 to May 31, 2016 at the ED of the Research and Training Hospital in İstanbul. A total of 136 patients were evaluated, and HEARTS3 scores were calculated at the second, third, and sixth hours. Receiver operating characteristic (ROC) curves were used to calculate the specificity, sensitivity, negative predictive value (NPV) and positive predictive value (PPV) of these scores. The primary outcome was the occurrence of major adverse cardiac events (MACEs) within 30 days.
In total, 29 patients with MACEs and 107 patients without MACEs were identified within 30 days. Based on the ROC curve, the cutoff value for early discharge was 6. The area under curve (AUC) values were 0.943, 0.963 and 0.976 at the second, third, and sixth hours, respectively. The sensitivity of the second-hour HEARTS3 score was 96.6%, and the NPV was 98.6%. Both the sensitivity and NPV reached 100% at the sixth hour.
The HEARTS3 score was considered a feasible method for the prediction of MACEs. We concluded that a patient with a HEARTS3 score less than 6 may be discharged without serial troponin and ECG examination.
HEARTS3评分用于通过评估胸痛患者在第2小时末的检查结果来预测急性冠状动脉综合征。此外,美国心脏病学会(ACC)/美国心脏协会(AHA)2014年非ST段抬高急性冠状动脉综合征(NSTE-ACS)管理指南建议,作为1A级推荐,在第3小时和第6小时评估心肌肌钙蛋白水平。本研究旨在探讨HEARTS3评分在胸痛患者评估中的价值及其在确定患者是否符合急诊科早期出院条件方面的效用。
本研究于2016年3月1日至2016年5月31日在伊斯坦布尔研究与培训医院急诊科前瞻性开展。共评估了136例患者,并在第2小时、第3小时和第6小时计算HEARTS3评分。采用受试者操作特征(ROC)曲线计算这些评分的特异性、敏感性、阴性预测值(NPV)和阳性预测值(PPV)。主要结局是30天内发生的主要不良心脏事件(MACE)。
30天内共识别出29例发生MACE的患者和107例未发生MACE的患者。根据ROC曲线,早期出院的临界值为6。第2小时、第3小时和第6小时的曲线下面积(AUC)值分别为0.943、0.963和0.976。第2小时HEARTS3评分的敏感性为96.6%,NPV为98.6%。在第6小时,敏感性和NPV均达到100%。
HEARTS3评分被认为是预测MACE的一种可行方法。我们得出结论,HEARTS3评分低于6的患者可能无需进行系列肌钙蛋白和心电图检查即可出院。